ºñ¹Ð¹øÈ£
(°Ô½Ã¹° ÀÛ¼º½Ã ÀÔ·ÂÇÑ Æнº¿öµå¸¦ ÀÔ·ÂÇϼ¼¿ä)
HTML¾²±â
À̸§
¸µÅ©
÷ºÎÆÄÀÏ
¼öÁ¤¾ÈÇÔ
÷ºÎÆÄÀϼöÁ¤
÷ºÎÆÄÀÏ»èÁ¦
(
÷ºÎÆÄÀÏÀ» ¼öÁ¤ÇÏ°íÀÚ ÇÒ¶§¸¸)
Á¦¸ñ
Updated clinical data for Glivec¢ç show higher response rates and longer responses in CML patients - doc ÈÀÏÀÔ´Ï´Ù. ´Ù¿î·Îµå¹ÞÀ¸¼¼¿ä. -
±Û¸®º¤ °¡°ÝÀÎÇÏ, ÀǾàÇ° °ø°ø¼º °È¸¦ À§ÇÑ °øµ¿´ëÃ¥À§¿øȸ
Korean Progressive Network
Jinbo.Net
No CopyRight, Just CopyLeft!!